BennuBio has assumed control of an existing UNM licence for cytometer technology, securing commitments from three investors to target a commercial release by next year.

BennuBio, a US-based cell processing technology spinout of University of New Mexico (UNM), has obtained $1.5m in funding from Tramway Venture Partners, Cottonwood Technology Fund and Sun Mountain Capital.

The deal was arranged through state government-backed fund-of-funds New Mexico Catalyst Fund, which is managed by Sun Mountain Capital and has supplied capital to both Tramway and Cottonwood.

BennuBio expects to add another $500,000 from either the round’s existing subscribers or new investors over coming weeks, according to the Albuquerque Journal.

…